ArticleMedicine2017

Rapidly decreasing level of prostate-specific antigen during initial androgen deprivation therapy is a risk factor for early progression to castration-resistant prostate cancer: A retrospective study.

Guangjie Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.